BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23439752)

  • 41. Primary granulocytic sarcoma of the ovary.
    Sreejith G; Gangadharan VP; Elizabath KA; Preetha S; Chithrathara K
    Am J Clin Oncol; 2000 Jun; 23(3):239-40. PubMed ID: 10857884
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimizing Cardiovascular Care in Children With Acute Myeloid Leukemia to Improve Cancer-Related Outcomes.
    Armenian SH; Ehrhardt MJ
    J Clin Oncol; 2019 Jan; 37(1):1-6. PubMed ID: 30422740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neutropenic enterocolitis in acute myeloid leukemia.
    Colovic N; Rajic Z; Sretenovic M; Stojkovic M; Colovic M
    Acta Chir Iugosl; 2004; 51(2):127-31. PubMed ID: 15771304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rare cytogenetic abnormalities in acute myeloid leukemia transformed from Fanconi anemia - a case report.
    Hussain S; Adil SN
    BMC Res Notes; 2013 Aug; 6():316. PubMed ID: 23937881
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does more intensive treatment cure more patients with acute myeloid leukemia? The BGMT Group.
    Reiffers J; Maraninchi D; Rigal-Huguet F; Michallet M; Marit G; Stoppa AM; Attal M; Hollard D
    Semin Hematol; 1991 Jul; 28(3 Suppl 4):90-2. PubMed ID: 1780761
    [No Abstract]   [Full Text] [Related]  

  • 46. [Significance of monitoring cerebrospinal fluid leukocyte counts in managing central nervous system disease of acute myeloid leukemia in patients presenting with intracerebral hemorrhage upon initial examination].
    Kawahara M; Teramoto Y; Asai A; Nagai S; Iwasa M; Fujishiro A; Nishimura R; Minamiguchi H; Tsuji A; Kito K; Andoh A
    Rinsho Ketsueki; 2018; 59(12):2578-2582. PubMed ID: 30626792
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Acute myelogenous leukemia complicated by compartment syndrome].
    Takahashi R; Inaba T; Shimazaki C
    Rinsho Ketsueki; 2002 May; 43(5):389-91. PubMed ID: 12096493
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular Complete Remission Following Ivosidenib in a Patient With an Acute Undifferentiated Leukemia.
    Patel SH; Vasu S; Guo L; Lemaster O; Byrd JC; Walker A
    J Natl Compr Canc Netw; 2020 Jan; 18(1):6-10. PubMed ID: 31910380
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conversion disorder with convulsion and motor deficit mimicking the adverse effects of high-dose Ara-C treatment in a posttransplant acute myeloid leukemia patient: a case report and review of the literature.
    Onishi H; Kamijo A; Onose M; Yamada T; Mizuno Y; Ito M; Saito H; Maruta I
    Palliat Support Care; 2004 Mar; 2(1):79-82. PubMed ID: 16594237
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis of granulocytic sarcoma facilitated by monoclonal antibodies.
    Juneja SK; Pilkington GR; Ding JC; Cooper IA
    Pathology; 1986 Oct; 18(4):469-72. PubMed ID: 3469612
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence-Based Minireview: Longitudinal geriatric assessment in quality care for older patients with hematologic malignancies.
    Lin RJ; Klepin HD
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):59-62. PubMed ID: 31808857
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiac Tamponade as the Initial Presentation of Acute Myeloid Leukemia: A Case Report with Review of the Literature.
    Karmo D; Hafeez A; Halalau A; Yadav S
    Case Rep Oncol Med; 2018; 2018():8201917. PubMed ID: 29780652
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapy-related myeloid neoplasm in a patient with TP53 mutation: a dilemma in allogeneic stem cell transplant.
    Kim MK; Cho HS; Bae YK; Lee KH; Ki CS; Lee ST; Hyun MS
    Leuk Lymphoma; 2010 Jun; 51(6):1144-7. PubMed ID: 20443677
    [No Abstract]   [Full Text] [Related]  

  • 54. Induction and postremission therapy: new agents.
    Stone RM
    Leukemia; 2003 Mar; 17(3):496-8. PubMed ID: 12646937
    [No Abstract]   [Full Text] [Related]  

  • 55. A Case of Therapy-Related Acute Myeloid Leukemia in a Patient With Heterozygous Mutations in the Ataxia Telangiectasia Mutated Gene.
    Shieh A; Mohamed AA
    J Hematol; 2017 Oct; 6(4):96-100. PubMed ID: 32300401
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute myeloid leukemia with hepatic infiltration presenting as obstructive jaundice.
    Walsh LR; Yuan C; Boothe JT; Conway HE; Mindiola-Romero AE; Barrett-Campbell OO; Yerrabothala S; Lansigan F
    Leuk Res Rep; 2021; 15():100251. PubMed ID: 34141563
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Minimal residual disease in acute leukemia.
    Gerhartz HH; Schmetzer H
    Eur J Cancer; 1991; 27(6):809-10. PubMed ID: 1829932
    [No Abstract]   [Full Text] [Related]  

  • 58. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: are we closer to knowing who needs it?
    Lekakis LJ; Cooper BW; de Lima MG
    Curr Hematol Malig Rep; 2014 Jun; 9(2):128-37. PubMed ID: 24664820
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pre-transplant CRP-albumin ratio as a biomarker in patients receiving haploidentical allogeneic hematopoietic transplantation: Developing a novel DRCI-based nomogram.
    Wang K; Jian X; Xu Z; Wang H
    Front Immunol; 2023; 14():1128982. PubMed ID: 36875097
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology.
    Xu L; Chen H; Chen J; Han M; Huang H; Lai Y; Liu D; Liu Q; Liu T; Jiang M; Ren H; Song Y; Sun Z; Wang J; Wu D; Zhou D; Zou P; Liu K; Huang X
    J Hematol Oncol; 2018 Mar; 11(1):33. PubMed ID: 29495966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.